Description

Send us a text

Welcome back Rounds Table Listeners! We are back today with our Classic Rapid Fire Podcast! This week, Drs. Mike and John Fralick discuss two recent papers examining the effect of glucagon-like peptide-1 receptor agonists (GLP1's) on patients living with Parkinson’s disease. Two papers, here we go!

1. Trial of Lixisenatide in Early Parkinson's Disease (0:00 – 10:24).
2. Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease (10:25 – 17:40).

And for the Good Stuff:

• Port Blandford artist creates portraits from Scotch tape (17:41 – 18:33).
• Rheumatology for the Royal College podcast (18:34 – 19:42).

This episode is sponsored by Northern Ontario Resident Streamlined Training and Reimbursement Program (NORSTAR). Check out details here!

Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods